Sigmoidoscopy

Although adherence to standardized reporting guidelines ranged from 82.4% to 92.2% in published trials of colorectal cancer screening, researchers found that reporting of trial registration and informed consent materials could be improved.

Colonoscopy screening reduced the incidence of colorectal cancer and related mortality by 30% and 32%, respectively, compared with usual care, although the benefit was less than that of sigmoidoscopy where no screening exists, data showed.

With the exception of sigmoidoscopy, common cancer screening tests do not appear to extend patients’ lifetimes, according to the results of research published in JAMA Internal Medicine.

The protective effect of a single flexible sigmoidoscopy screening in older adults was maintained for up 15 years against colorectal cancer incidence and for up to 19 years against mortality, according to a randomized controlled trial.

LAS VEGAS – Flexible sigmoidoscopy with distal colon biopsies was an acceptable initial diagnostic test among patients with suspected immunotherapy-mediated colitis, according to a presentation at the ACG Annual Scientific Meeting.

The ACP has issued a new evidence-based guidance statement on screening for colorectal cancer screening in asymptomatic adults with average risk.

Multiple rounds of fecal immunochemical tests sent to patients through the mail had a higher diagnostic yield for advanced neoplasia among invitees compared with one-time flexible sigmoidoscopy or one-time colonoscopy, according to study results.